Atlas Trials

Evaluate the Safety and Effectiveness of The Tixel Fractional System in the Treatment of Meibomian Gland Disfunction

Clinical trial NCT04889950 · COMPLETED

Trial details

NCT number
NCT04889950
Sponsor
Novoxel Ltd.
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Dry Eye SyndromesDry EyeMeibomian Gland Dysfunction
Start date
2021-10-26
Primary completion
2023-01-04
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.